May | 2015 | Peptonic Medical

Home / 2015 / May

PEPTONIC medical AB (publ) deltar på Småbolagsdagen i Stockholm den 8:e juni

- May 29, 2015

PEPTONIC medical (publ) – ett bolag som utvecklar läkemedel baserade på oxytocin – kommer att delta på Småbolagsdagen i Stockholm den 8:e juni. Småbolagsdagen arrangeras av Redeye och Aktiespararna på

About us

PEPTONIC Medical is an innovative Swedish pharmaceutical company developing and commercializing safe and effective products for the treatment of menopausal symptoms, such as vaginal atrophy. VagiVital® is a registered trademark of PEPTONIC Medical. The product is being commercialised for the non-prescription use for the treatment of vaginal atrophy.

The Company was founded in 2009 and its first candidate drug product is Vagitocin® – an estrogen-free oxytocin based product for the treatment of vaginal atrophy in clinical development phase 2.

Oxytocin has a long history of safe and effective medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women.

PEPTONIC medical AB (publ) deltar på Småbolagsdagen i Stockholm den 8:e juni

Recent Posts

Recent Comments

Archives

Categories

Meta

All press releases on Spotlightstockmarket.com

About us

Contact us

Dataskyddspolicy

Navigation